These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15633094)

  • 1. Influence of sex hormones, HIV status, and concomitant sexually transmitted infection on cervicovaginal inflammation.
    Ghanem KG; Shah N; Klein RS; Mayer KH; Sobel JD; Warren DL; Jamieson DJ; Duerr AC; Rompalo AM;
    J Infect Dis; 2005 Feb; 191(3):358-66. PubMed ID: 15633094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sexually transmitted infections and cervicovaginal dysplasia in a cohort of human immunodeficiency virus-positive women in Turin.
    Pugliese A; Saini A; Andronico L; Pagliano G; Gallo G
    Cancer Detect Prev; 2001; 25(1):32-9. PubMed ID: 11270419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of menopause on the innate antiviral activity of cervicovaginal lavage.
    Chappell CA; Isaacs CE; Xu W; Meyn LA; Uranker K; Dezzutti CS; Moncla BJ; Hillier SL
    Am J Obstet Gynecol; 2015 Aug; 213(2):204.e1-6. PubMed ID: 25818668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of immunologic markers in cervicovaginal fluid of HIV-infected and uninfected women: implications for the immunologic response to HIV in the female genital tract.
    Sha BE; D'Amico RD; Landay AL; Spear GT; Massad LS; Rydman RJ; Warner NA; Padnick J; Ackatz L; Charles LA; Benson CA
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Nov; 16(3):161-8. PubMed ID: 9390567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological microenvironments in the human vagina and cervix: mediators of cellular immunity are concentrated in the cervical transformation zone.
    Pudney J; Quayle AJ; Anderson DJ
    Biol Reprod; 2005 Dec; 73(6):1253-63. PubMed ID: 16093359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human immunodeficiency virus in plasma and cervicovaginal secretions in Filipino women.
    Natividad-Villanueva GU; Santiago E; Manalastas RM; Brown HW; Ingersoll J; Caliendo AM; Mayer KH; Cu-Uvin S
    Int J STD AIDS; 2003 Dec; 14(12):826-9. PubMed ID: 14678591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The molecular basis of nonoxynol-9-induced vaginal inflammation and its possible relevance to human immunodeficiency virus type 1 transmission.
    Fichorova RN; Tucker LD; Anderson DJ
    J Infect Dis; 2001 Aug; 184(4):418-28. PubMed ID: 11471099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variation of human immunodeficiency virus type 1 viral RNA levels in the female genital tract: implications for applying measurements to individual women.
    Coombs RW; Wright DJ; Reichelderfer PS; Burns DN; Cohn J; Cu-Uvin S; Baron PA; Cohen MH; Landay AL; Lewis S; Kovacs A;
    J Infect Dis; 2001 Nov; 184(9):1187-91. PubMed ID: 11598843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of pregnancy on anti-HIV activity of cervicovaginal secretions.
    Hughes BL; Dutt R; Raker C; Barthelemy M; Rossoll RM; Ramratnam B; Wira CR; Cu-Uvin S
    Am J Obstet Gynecol; 2016 Dec; 215(6):748.e1-748.e12. PubMed ID: 27393267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic inflammation with increased human immunodeficiency virus (HIV) RNA expression in the vaginal epithelium of HIV-infected Thai women.
    Cohn MA; Frankel SS; Rugpao S; Young MA; Willett G; Tovanabutra S; Khamboonruang C; VanCott T; Bhoopat L; Barrick S; Fox C; Quinn TC; Vahey M; Nelson KE; Weissman D
    J Infect Dis; 2001 Aug; 184(4):410-7. PubMed ID: 11471098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent douching and clinical outcomes among HIV-infected women.
    Clark RA; Theall KP; Amedee AM; Kissinger PJ
    Sex Transm Dis; 2007 Dec; 34(12):985-90. PubMed ID: 17621248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV and the vaginal ecosystem.
    Denenberg R
    GMHC Treat Issues; 1997; 11(7-8):8-10. PubMed ID: 11364659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal serpin A1 and A3 levels in HIV highly exposed sero-negative women are affected by the menstrual cycle and hormonal contraceptives but are independent of epidemiological confounders.
    Rahman S; Rabbani R; Wachihi C; Kimani J; Plummer FA; Ball TB; Burgener A
    Am J Reprod Immunol; 2013 Jan; 69(1):64-72. PubMed ID: 22971020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of vaginal candidiasis on the shedding of human immunodeficiency virus in cervicovaginal secretions.
    Spinillo A; Zara F; Gardella B; Preti E; Mainini R; Maserati R
    Am J Obstet Gynecol; 2005 Mar; 192(3):774-9. PubMed ID: 15746671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cervicovaginal levels of lactoferrin, secretory leukocyte protease inhibitor, and RANTES and the effects of coexisting vaginoses in human immunodeficiency virus (HIV)-seronegative women with a high risk of heterosexual acquisition of HIV infection.
    Novak RM; Donoval BA; Graham PJ; Boksa LA; Spear G; Hershow RC; Chen HY; Landay A
    Clin Vaccine Immunol; 2007 Sep; 14(9):1102-7. PubMed ID: 17671228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV/AIDS in women: an expanding epidemic.
    Quinn TC; Overbaugh J
    Science; 2005 Jun; 308(5728):1582-3. PubMed ID: 15947174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-dependent cell-mediated cytotoxicity in cervical lavage fluids of human immunodeficiency virus type 1--infected women.
    Battle-Miller K; Eby CA; Landay AL; Cohen MH; Sha BE; Baum LL
    J Infect Dis; 2002 Feb; 185(4):439-47. PubMed ID: 11865395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gynecologic disease in women infected with human immunodeficiency virus type 1.
    Korn AP; Landers DV
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Aug; 9(4):361-70. PubMed ID: 7600103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervicovaginal secretions contribute to innate resistance to herpes simplex virus infection.
    John M; Keller MJ; Fam EH; Cheshenko N; Hogarty K; Kasowitz A; Wallenstein S; Carlucci MJ; Tuyama AC; Lu W; Klotman ME; Lehrer RI; Herold BC
    J Infect Dis; 2005 Nov; 192(10):1731-40. PubMed ID: 16235171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal herpes simplex virus type 2 coinfection increases the risk of perinatal HIV transmission: possibility to further decrease transmission?
    Bollen LJ; Whitehead SJ; Mock PA; Leelawiwat W; Asavapiriyanont S; Chalermchockchareonkit A; Vanprapar N; Chotpitayasunondh T; McNicholl JM; Tappero JW; Shaffer N; Chuachoowong R
    AIDS; 2008 Jun; 22(10):1169-76. PubMed ID: 18525263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.